Andreessen drums up a $450M fund to back their vision for engineering biology
Image: Vijay Pande, Andreessen Horowitz.
Andreessen Horowitz believes that AI and machine learning are creating a new biotech world with a lot less guesswork involved. And today they have a fresh $450 million fund to invest in the emerging field.
Two years ago, Stanford’s Vijay Pande took the first step with a $200 million inaugural fund. Then a few months ago Jorge Conde joined as a new partner in the small group, signaling today’s announcement. Conde jumped to Andreessen from Syros, where he was chief strategy officer. And he got out just ahead of a disastrous presentation a few days ago at ASH on weak results for their lead drug, which tanked the stock.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.